The new hopes of CETP inhibitors

被引：0
|
作者：
Farnier, M. [1 ]
机构：
[1] Point Med, Dijon, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2012年 / 16卷 / 04期
关键词：
HIGH-RISK; CORONARY; MASS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：98 / 100
页数：3
相关论文
共 50 条
  • [1] CETP Inhibitors - A New Inning?
    Hegele, Robert A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) : 1284 - 1285
  • [2] CETP inhibitors revisited
    Laufs, Ulrich
    Speer, Thimoteus
    EUROPEAN HEART JOURNAL, 2022, 43 (14) : 1425 - 1427
  • [3] Trials and Tribulations of CETP Inhibitors
    Tall, Alan R.
    Rader, Daniel J.
    CIRCULATION RESEARCH, 2018, 122 (01) : 106 - 112
  • [4] Obicetrapib-the Rebirth of CETP Inhibitors?
    Chang, Bliss
    Laffin, Luke J.
    Sarraju, Ashish
    Nissen, Steven E.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (10) : 603 - 608
  • [5] Design of a novel class of biphenyl CETP inhibitors
    Lu, Zhijian
    Napolitano, Joann B.
    Theberge, Ashleigh
    Ali, Amjad
    Hammond, Milton L.
    Tan, Eugene
    Tong, Xinchun
    Xu, Suoyu S.
    Latham, Melanie J.
    Peterson, Laurence B.
    Anderson, Matt S.
    Eveland, Suzanne S.
    Guo, Qiu
    Hyland, Sheryl A.
    Milot, Denise P.
    Chen, Ying
    Sparrow, Carl P.
    Wright, Samuel D.
    Sinclair, Peter J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7469 - 7472
  • [6] The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis
    Dangas, Katerina
    Navar, Ann-Marie
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (06) : 622 - 632
  • [7] CETP Inhibitors: Should We Continue to Pursue This Pathway?
    Nicholls, Stephen J.
    Nelson, Adam J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (12) : 915 - 923
  • [8] The mystery of evacetrapib-why are CETP inhibitors failing?
    Nicholls, Stephen J.
    Bubb, Kristen
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (03) : 127 - 130
  • [9] SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors
    Lu, Zhijian
    Chen, Yi-Heng
    Napolitano, Joann B.
    Taylor, Gayle
    Ali, Amjad
    Hammond, Milton L.
    Deng, Qiaolin
    Tan, Eugene
    Tong, Xinchun
    Xu, Suoyu S.
    Latham, Melanie J.
    Peterson, Laurence B.
    Anderson, Matt S.
    Eveland, Suzanne S.
    Guo, Qiu
    Hyland, Sheryl A.
    Milot, Denise P.
    Chen, Ying
    Sparrow, Carl P.
    Wright, Samuel D.
    Sinclair, Peter J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 199 - 203
  • [10] Can we revive CETP-inhibitors for the prevention of cardiovascular disease?
    Nicholls, Stephen J.
    Ray, Kausik K.
    Nelson, Adam J.
    Kastelein, John J. P.
    CURRENT OPINION IN LIPIDOLOGY, 2022, 33 (06) : 319 - 325
12345